Results 11 to 20 of about 2,908,134 (284)

Effect of Mutated ids Overexpression on IDS Enzyme Activity and Developmental Phenotypes in Zebrafish Embryos: A Valuable Index for Assessing Critical Point-Mutations Associated with Mucopolysaccharidosis Type II Occurrence in Humans

open access: yesDiagnostics, 2020
Mucopolysaccharidosis type II (MPS II) is an X-linked disorder resulting from a deficiency in iduronate 2-sulfatase (IDS), which is reported to be caused by gene mutations in the iduronate 2-sulfatase (IDS) gene.
Cheng-Yung Lin   +6 more
doaj   +2 more sources

IDconverter and IDClight: Conversion and annotation of gene and protein IDs [PDF]

open access: yesBMC Bioinformatics, 2007
Background Researchers involved in the annotation of large numbers of gene, clone or protein identifiers are usually required to perform a one-by-one conversion for each identifier.
Díaz-Uriarte Ramón   +3 more
doaj   +4 more sources

Deep Genotyping of the IDS Gene in Colombian Patients with Hunter Syndrome. [PDF]

open access: yesJIMD Rep, 2015
Mucopolysaccharidosis type II (MPSII), also known as Hunter syndrome, is an X-linked disorder caused by mutations in the iduronate 2 sulfatase (IDS) gene. This enzyme catalyzes the initial step in the catabolism of heparan sulfate and dermatan sulfate; thus, its deficiency leads to the accumulation of these glycosaminoglycans.
Galvis J   +3 more
europepmc   +4 more sources

DAVID gene ID conversion tool [PDF]

open access: yesBioinformation, 2008
Our current biological knowledge is spread over many independent bioinformatics databases where many different types of gene and protein identifiers are used. The heterogeneous and redundant nature of these identifiers limits data analysis across different bioinformatics resources.
Da Wei, Huang   +5 more
openaire   +2 more sources

Functional assessment of the genetic findings indicating mucopolysaccharidosis type II in the prenatal setting

open access: yesJIMD Reports, 2021
Mucopolysaccharidosis type II (MPS II) is a multi‐systemic disorder arising due to pathogenic variants in the gene located on chromosome Xq28 encoding the lysosomal enzyme, iduronate 2‐sulfatase (IDS).
Maria Fuller, David Ketteridge
doaj   +1 more source

Mucopolysaccharidosis type II (Hunter syndrome) in a boy from the Republic of Serbia: A case report [PDF]

open access: yesKragujevac Journal of Science, 2023
Mucopolysaccharidosis type II or Hunter syndrome is a hereditary, progressive disease that occurs due to the deposition of acidic glucosaminoglycans in lysosomes, due to hereditary deficits of specific degradation enzymes.
Tubić-Vukajlović Jovana M.   +3 more
doaj  

Identity crisis? The need for systematic gene IDs [PDF]

open access: yesTrends in Parasitology, 2011
Recent years have seen an explosion in the availability of protozoan pathogen genome sequences. Although data regarding the underlying genome sequence remain relatively stable after the initial draft, understanding of specific gene function is increasing rapidly.
Marilyn, Parsons   +4 more
openaire   +2 more sources

Id genes are essential for early heart formation [PDF]

open access: yesGenes & Development, 2017
Deciphering the fundamental mechanisms controlling cardiac specification is critical for our understanding of how heart formation is initiated during embryonic development and for applying stem cell biology to regenerative medicine and disease modeling.
Cunningham, Thomas   +18 more
openaire   +4 more sources

Inversion of the IDS gene resulting from recombination with IDS-related sequences is a common cause of the Hunter syndrome

open access: yes, 1995
We have recently described the identification of a second IDS locus (IDS-2) located within 90 kb telomeric of the IDS gene (Bondeson et al. submitted). Here, we show that this region is involved in a recombination event with the IDS gene in about 13% of ...
Carlberg, Britt-Marie,   +6 more
core   +8 more sources

A novel mucopolysaccharidosis type II mouse model with an iduronate-2-sulfatase-P88L mutation

open access: yesScientific Reports, 2023
Mucopolysaccharidosis type II (MPS II) is a lysosomal storage disorder characterized by an accumulation of glycosaminoglycans (GAGs), including heparan sulfate, in the body.
Ryuichi Mashima   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy